Hanesbrands Inc (NYSE: HBI) Seen Running Too Hot, Let’s Look At This More Closely

Currently, there are 351.78M common shares owned by the public and among those 348.27M shares have been available to trade.

The company’s stock has a 5-day price change of -3.00% and 35.86% over the past three months. HBI shares are trading 88.57% year to date (YTD), with the 12-month market performance up to 117.88% higher. It has a 12-month low price of $3.71 and touched a high of $9.10 over the same period. HBI has an average intraday trading volume of 6.30 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -0.14%, 8.74%, and 39.79% respectively.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Institutional ownership of Hanesbrands Inc (NYSE: HBI) shares accounts for 98.32% of the company’s 351.78M shares outstanding.

It has a market capitalization of $2.96B and a beta (3y monthly) value of 1.64. The earnings-per-share (ttm) stands at -$0.66. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.52% over the week and 3.95% over the month.

Earnings per share for the fiscal year are expected to increase by 560.13%, and 33.58% over the next financial year.

Looking at the support for the HBI, a number of firms have released research notes about the stock. UBS stated their Buy rating for the stock in a research note on November 26, 2024, with the firm’s price target at $9-$11. Credit Suisse coverage for the Hanesbrands Inc (HBI) stock in a research note released on November 10, 2022 offered a Neutral rating with a price target of $7. Barclays on their part issued Equal Weight rating on June 08, 2022.

Most Popular

Related Posts